Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.43 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14936915 | 0.81 | HPGD (0.62) | ALDH1A1HPGDMAOBKDM4EMEN1 | |
| SCHEMBL6669050 | 0.81 | KDM4E (0.52) | ALDH1A1SMN1; SMN2HPGDKDM4EPOLB | |
| SCHEMBL6671064 | 0.80 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2HPGDKDM4EMEN1 | |
| SCHEMBL27813060 | 0.78 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2HPGDKDM4EAPOBEC3A | |
| SCHEMBL8211971 | 0.78 | MAOB (0.53) | ALDH1A1SMN1; SMN2HPGDGRIN2BMAOB | |
| SCHEMBL6668853 | 0.78 | MAOB (0.53) | ALDH1A1SMN1; SMN2HPGDGRIN2BMAOB | |
| SCHEMBL27990368 | 0.78 | EPHX1 (0.53) | — | |
| SCHEMBL11349211 | 0.78 | EPHX1 (0.59) | ALDH1A1SMN1; SMN2HPGDKDM4EAPOBEC3A | |
| SCHEMBL3849886 | 0.77 | ALDH1A1 (0.54) | ALDH1A1HPGDMAOBKDM4EMEN1 | |
| SCHEMBL21895653 | 0.77 | HPGD (0.44) | ALDH1A1SMN1; SMN2HPGDGRIN2BMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822724-B2 | Method for producing carboxylic acid amide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-09-02 | — | — | US | disclosed |
| EP-2599769-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | Sumitomo Chemical Company Limited (JP) | 2013-06-05 | — | — | EP | disclosed |
| US-20130123505-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | SUMITOMO CHEMICAL COMPANY, LIMITED | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123505-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID AMIDE | HCAR2, NAAA, FAAH2 | ALDH1A1 161/4885SMN1; SMN2 2769/4885HPGD 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.